Many publications support the link between MM9, TIMP-1 and tumor cell survival demonstrating a high statistically significant association between high tumor or plasma levels of TIMP-1 and poor cancer patient outcome [5, 34, 35]. This evidence concerns the gene TIMP1 and cancer.